If you liked this article you might like

Biotech Premarket Movers: SGMO, IPXL, PTLA
Mylan Crushed by Trump, Cigna and CVS -- All In Two Days
Insulin Drug Offers Hope for MannKind
Patent Victory Secures Lilly Hold on Cancer Drug Until 2022